Posts by: Marina Anastasiou

News

A new study led by a research team at Oxford University suggests that pharmaceutically copying a genetic variant of a key protein could be a potential therapeutic strategy for autoimmune diseases. ... Read more

November 4, 2016November 4, 2016

Biosimilar of Humira for Rheumatoid Arthritis Passes Critical Phase 3 Trial

News, rheumatoid arthritis

Boehringer Ingelheim‘s BI 695501 has been deemed effectively equivalent to Humira (adalimumab) in patients with active rheumatoid arthritis (RA), according to the results of a crucial Phase 3 clinical trial comparing the two ... Read more

October 19, 2016October 19, 2016

Wheat Protein May Be Linked to Inflammation in Rheumatoid Arthritis, Study Says

News

Inflammation in people with rheumatoid arthritis may be promoted by a group of proteins, called amylase-trypsin inhibitors (ATIs), that are commonly found in wheat, researchers reported. ATIs might also play a role in ... Read more